Developer docs
API playgroundTry for free, no card

Search company profiles

Gynopolis

Full company profile

uuid003eylp

Namestring
Gynopolis
Legal namestring
Gynopolis
Websiteurl
gynopolis.in
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Gynopolis is an India-based pharmaceutical company operating as a specialized women's healthcare division of Micropolis Lifesciences Private Limited, headquartered in Panchkula, Haryana. The company develops, manufactures, and distributes a portfolio of 60+ branded gynaecology products across eight therapeutic categories, including fertility and PCOS management, oral contraceptives, progesterone therapies, lactation support, menstrual health, and UTI/vaginal care. Manufacturing is conducted in WHO-GMP certified in-house facilities, and the product line spans tablets, capsules, sachets, syrups, injections, and topical formulations developed by an internal R&D team.

The company monetizes its portfolio through a PCD (Propaganda cum Distribution) pharma franchise model, granting territorial monopoly rights to franchise partners across India who purchase, market, and distribute products to gynaecologists, obstetricians, hospitals, clinics, and pharmacies. It supplements this primary distribution channel with a third-party manufacturing service for external brand owners and engages healthcare professionals directly via field sampling, visual aids, and healthcare events. End consumers reached through this network are women across all life stages, with the company claiming 5,000+ customers and 175,000+ couples supported through fertility formulations.

Short descriptiontext

Gynopolis is an India-based pharmaceutical division of Micropolis Lifesciences that manufactures and distributes 60+ branded gynaecology products through a PAN-India PCD pharma franchise network, serving franchise partners, gynaecologists, and women across all life stages.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersPanchkula, India
HQ citystring
Panchkula
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
women's health pharmaceuticals, gynecological formulations, gynae PCD franchise, fertility and PCOS medicines, PCD pharma manufacturing India
Industry4 codes
PRIMARYHLAIACAN
Women’s Health & Reproductive Specialty Pharmaceuticals
SECONDARYHLAIAAAJ
Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRADAGAK
Women’s Health Supplements (Prenatal, Menopause, Hormonal)
SECONDARYHLAKAJAJ
Sexual & Reproductive Health (STI Care, Vulvovaginal Disorders)
NAICS code3 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Pharmaceutical and Medicine Manufacturing3254
  • Drugs and Druggists' Sundries Merchant Wholesalers424210
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Medicinal Chemicals & Botanical Products2833
Product category
Women's Health Pharmaceuticals
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1PCD Pharma Franchise Product Sales
TypeOne Time License
Description

Revenue is generated through the sale of gynecological pharmaceutical products via their PCD (Propaganda cum Distribution) franchise network. Franchise holders purchase products from the company and distribute them in their designated territories. The company offers monopoly rights to franchise partners and provides marketing collateral and support.

gynopolis.in
2Third Party Manufacturing
TypeProfessional Services
Description

The company offers third-party manufacturing services for gynecological products, allowing other companies to manufacture products under their brand or配方.

gynopolis.in
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Technology or R&D, Marketing or Sales, Operations, Personnel
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1WinVision
Description

Vision care division mentioned in navigation as part of Micropolis group.

gynopolis.in
+1 more record
Core offering1 text field

Gynopolis manufactures and distributes a complete range of women's health pharmaceutical formulations spanning fertility care, PCOS management, contraception, menstrual health, lactation support, UTI and vaginal care, and supplementation. The company sells its branded products primarily through a PCD (Propaganda cum Distribution) pharma franchise model, granting franchise holders monopoly distribution rights in designated Indian territories, and additionally offers third-party manufacturing services for gynecological products.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • 1,75,000+ couples have overcome infertility using Gynopolis fertility formulations
+1 more record
Product overview1 text field

Gynopolis is a specialized pharmaceutical company focused exclusively on women's healthcare, operating as a division of Micropolis Lifesciences Private Limited. The company offers a comprehensive portfolio of over 60 gynecological and reproductive health products across 8 major categories including Gynaecology, Lactation Related Products, Menstrual Problem Related Products, Oral Contraceptives, PCOS Management & Female Infertility, Progesterone Range, Supplementation & Nutrition, and UTI & Vaginal Care Products. The product portfolio includes branded formulations such as ALKATWIST, ARGIDAILY, ARGIDAILY PLUS, Carelacto, Clinpolis, CLINPOLIS-TZ, CLOMIPOLIS, Cranpolis, CYSTOKEY, OVAPOLIS, MYDIOL, PREGHOLD series, MENOPOLIS, FOLICOSA, CALDUB, DORNIK-PLUS, GYNOPOLIS-DHA, and contraceptive products like THREEWEEKS and NEXTSTEP-21DAYS. These products address conditions across all stages of a woman's life including early womanhood (menstrual care, UTI treatment), contraception phase, family planning (PCOS, infertility, progesterone-based therapies), and motherhood (lactation support). Gynopolis operates primarily through a PCD (Propaganda cum Distribution) pharma franchise model, providing business opportunities for distributors and entrepreneurs to market these products with monopoly rights in specific territories.

Product and service33 records
1ALKATWIST™
CategoryUTI & Vaginal Care Products
Description

UTI and vaginal care product formulated for treating urinary tract infections in women.

2ARGIDAILY®
CategoryPCOS Management & Female Infertility
Description

L-Arginine 3gm and Proanthocyanidin 75mg granules sachet for PCOS management and female infertility support.

3ARGIDAILY™ PLUS
CategoryPCOS Management & Female Infertility
Description

L-Arginine 3gm with Cyanocobalamine, Vitamin B12, Folic Acid, and DHA granules in orange flavour for female fertility support.

4Carelacto™
CategoryLactation Related Products
Description

Capsule formulation for lactation support containing Shatavri, Ashwagandha, Yastimadhu, Methi, and Lasuna extracts.

5Carelacto™ Lactation Powder
CategoryLactation Related Products
Description

Powder formulation for supporting healthy lactation and milk supply in nursing mothers.

6Clinpolis
CategoryUTI & Vaginal Care Products
Description

Pharmaceutical product for UTI and vaginal care treatment.

7CLINPOLIS™ – TZ
CategoryUTI & Vaginal Care Products
Description

Combination antibiotic product for treating complex UTI and vaginal infections.

8CLOMIPOLIS™ M 100
CategoryPCOS Management & Female Infertility
Description

Clomiphene Citrate 100mg with Melatonin 3mg for ovulation induction and PCOS management.

9Cranpolis® Syrup
CategoryUTI & Vaginal Care Products
Description

Cranberry-based suspension for UTI prevention and urinary tract health support.

10CRANPOLIS™
CategoryUTI & Vaginal Care Products
Description

Cranberry-based formulation for urinary tract infection care and vaginal health.

11CYSTOKEY™
CategoryPCOS Management & Female Infertility
Description

Myo-Inositol 1000mg with L-Methylfolate and Vitamin D3 tablets for PCOS management and metabolic support.

12CYSTOKEY™ – MET B/L
CategoryPCOS Management & Female Infertility
Description

Myo-Inositol combination with Metformin for enhanced PCOS and metabolic syndrome management.

13OVAPOLIS-2.5
CategoryPCOS Management & Female Infertility
Description

Letrozole 2.5mg tablet for ovulation induction and fertility treatment.

14MYDIOL-35
CategoryPCOS Management & Female Infertility
Description

Cyproterone acetate 2mg and Ethinyl estradiol 0.035mg tablet for hormonal balance and acne management in PCOS.

15PREGHOLD Depot 250
CategoryProgesterone Range
Description

Hydroxyprogesterone Caproate 250mg injection for pregnancy support and prevention of preterm birth.

16PREGHOLD-MP
CategoryProgesterone Range
Description

Medroxyprogesterone Acetate 10mg tablet for hormonal support and menstrual regulation.

17PREGHOLD 300 SR
CategoryProgesterone Range
Description

Micronized Progesterone 300mg sustained release tablet for luteal phase support and fertility treatment.

18MENOPOLIS
CategorySupplementation & Nutrition
Description

Soya Isoflavones, Calcitriol, Calcium, Vitamin K and Magnesium combination for menopause symptom management.

19ESTRAPOLIS
CategoryProgesterone Range
Description

Estradiol Valerate 2mg tablet for hormone replacement therapy.

20TEXAPOLIS-ET
CategoryMenstrual Problem Related Products
Description

Tranexamic acid 250mg and Etamsylate 250mg combination for menstrual bleeding management.

21PRIMOTWIST 500
CategorySupplementation & Nutrition
Description

Evening Primrose 500mg supplement for women's health and hormonal balance.

22TEXAPOLIS-MF
CategoryMenstrual Problem Related Products
Description

Tranexamic acid 500mg and Mefenamic acid 250mg tablet for heavy menstrual bleeding relief.

23PREGHOLD-200 SR
CategoryProgesterone Range
Description

Natural Micronized Progesterone 200mg sustained release tablet for fertility support and hormone balance.

24FOLICOSA
CategorySupplementation & Nutrition
Description

Folic acid 5mg and DHA 200mg supplement for prenatal care and fetal development support.

25CALDUB
CategorySupplementation & Nutrition
Description

Coral Calcium tablet providing Calcium 225mg and Vitamin D3 500IU for bone health support.

26DORNIK-PLUS
CategoryMenstrual Problem Related Products
Description

Drotaverine 80mg and Mefenamic acid 250mg tablet for menstrual pain and dysmenorrhea relief.

27PRIMOTWIST 1000
CategorySupplementation & Nutrition
Description

Evening Primrose 1000mg supplement for women's health and hormonal support.

28GYNOPOLIS-DHA
CategorySupplementation & Nutrition
Description

L-methylfolate, Mecobalamine, Pyridoxal 5 phosphate, DHA and Vitamin D3 combination for prenatal nutrition.

29THREEWEEKS
CategoryOral Contraceptives
Description

Desogestrel 0.15mg and Ethinyl Estradiol 0.02mg oral contraceptive pill.

30NEXTSTEP-21DAYS
CategoryOral Contraceptives
Description

Levonorgestrel 0.15mg and Ethinyl Estradiol 0.03mg oral contraceptive for family planning.

31DYDROZING™
CategoryProgesterone Range
Description

Dydrogesterone 10mg tablet for progesterone support in fertility treatment and pregnancy maintenance.

32PCD Pharma Franchise
CategoryBusiness Model / Distribution Service
Description

Propaganda cum Distribution franchise opportunity allowing partners to market and distribute Gynopolis gynecological products in designated territories with monopoly rights, with marketing collateral and training support provided.

33Third-Party Manufacturing Service
CategoryContract Manufacturing Service
Description

Contract manufacturing service for gynecological products, allowing other companies to have formulations manufactured under their own brand or composition using Gynopolis's WHO-GMP certified facilities.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

Gynopolis is a division of Micropolis Lifesciences Private Limited. As a subsidiary, Gynopolis operates under the parent company's WHO-GMP certifications and infrastructure for manufacturing and distributing gynecological pharmaceutical products.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

India's largest PCD-franchise-based pharma company with broad women's health and gynecological offerings. Comparable on the PCD distribution model and women's health category, though it operates across many other therapeutic areas.

2Sun Pharmaceutical Industries
TypeBroad incumbent
Description

India's largest pharma company with global scale, broad OB/GYN and hormonal franchises, and deep doctor relationships across India — a dominant incumbent competing for the same prescription volume in gynae.

TypeDirect peer
Description

India-based specialty pharma with a focused fertility, hormonal, and gynecological portfolio. Its premium niche positioning in reproductive health and its distribution in India overlap closely with Gynopolis's core franchise.

TypeEmerging player
Description

Global women's health specialty company focused on contraception, fertility, menopause, and osteoporosis — a pure-play peer in women's health, though currently focused on Europe/International rather than India.

TypeBroad incumbent
Description

Major Indian pharma with established women's health, hormonal, and supplement brands and a robust India distribution network. A broader incumbent that overlaps with Gynopolis on contraception, hormonal, and supplementation categories.

TypeBroad incumbent
Description

Large Indian pharma with dedicated gynecology and women's healthcare marketing divisions. Competes for the same prescriber wallet in gynae therapies but is materially larger and more diversified across geographies.

TypeDirect peer
Description

Indian pharmaceutical company with a strong women's health, fertility, and hormonal therapy portfolio distributed across India via similar field and franchise models, making it a directly comparable gynae specialty peer.

TypeBroad incumbent
Description

India's largest pharma company by certain measures with presence in women's reproductive health, hormonal, and fertility categories. A broad incumbent whose gynae portfolio competes directly with Gynopolis in India's doctor channel.

TypeEmerging player
Description

Women's health pure-play spun out of Merck with a portfolio in contraception, fertility, and hormone therapy. Closely comparable on therapeutic focus but operates globally rather than via India's PCD franchise model.

TypeBroad incumbent
Description

One of India's largest pharma companies with a meaningful women's health and hormonal portfolio and pan-India field force. Overlaps with Gynopolis in gynae and fertility but spans far wider therapy areas and global markets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Gynopolis

Women's Health Pharmaceuticalsgynopolis.in

Gynopolis is an India-based pharmaceutical division of Micropolis Lifesciences that manufactures and distributes 60+ branded gynaecology products through a PAN-India PCD pharma franchise network, serving franchise partners, gynaecologists, and women across all life stages.

What Gynopolis does

Gynopolis is an India-based pharmaceutical company operating as a specialized women's healthcare division of Micropolis Lifesciences Private Limited, headquartered in Panchkula, Haryana. The company develops, manufactures, and distributes a portfolio of 60+ branded gynaecology products across eight therapeutic categories, including fertility and PCOS management, oral contraceptives, progesterone therapies, lactation support, menstrual health, and UTI/vaginal care. Manufacturing is conducted in WHO-GMP certified in-house facilities, and the product line spans tablets, capsules, sachets, syrups, injections, and topical formulations developed by an internal R&D team.

The company monetizes its portfolio through a PCD (Propaganda cum Distribution) pharma franchise model, granting territorial monopoly rights to franchise partners across India who purchase, market, and distribute products to gynaecologists, obstetricians, hospitals, clinics, and pharmacies. It supplements this primary distribution channel with a third-party manufacturing service for external brand owners and engages healthcare professionals directly via field sampling, visual aids, and healthcare events. End consumers reached through this network are women across all life stages, with the company claiming 5,000+ customers and 175,000+ couples supported through fertility formulations.

Gynopolis firmographics

Firmographics
Name
Gynopolis
Legal name
Gynopolis
Website
https://gynopolis.in
Company type
Private
Operating status
Operating
Short description
Gynopolis is an India-based pharmaceutical division of Micropolis Lifesciences that manufactures and distributes 60+ branded gynaecology products through a PAN-India PCD pharma franchise network, serving franchise partners, gynaecologists, and women across all life stages.
Ownership category
akta.pro rank

Gynopolis industry classification

Industry
Product category
Women's Health Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
SIC
Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYHLAIACAN
Women’s Health & Reproductive Specialty Pharmaceuticals
SECONDARYHLAIAAAJ
Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
SECONDARYCRADAGAK
Women’s Health Supplements (Prenatal, Menopause, Hormonal)
SECONDARYHLAKAJAJ
Sexual & Reproductive Health (STI Care, Vulvovaginal Disorders)

Keywords

  • Women's health pharmaceuticals
  • Gynecological formulations
  • Gynae PCD franchise
  • Fertility and PCOS medicines
  • PCD pharma manufacturing India

Where Gynopolis is headquartered

Location

Headquarters

HQ city
Panchkula
HQ country
India
HQ region
Asia

Offices1 record

Markets served

Gynopolis business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Marketing or Sales, Operations, Personnel

Revenue model

  1. PCD Pharma Franchise Product Sales: Revenue is generated through the sale of gynecological pharmaceutical products via their PCD (Propaganda cum Distribution) franchise network. Franchise holders purchase products from the company and distribute them in their designated territories. The company offers monopoly rights to franchise partners and provides marketing collateral and support.
  2. Third Party Manufacturing: The company offers third-party manufacturing services for gynecological products, allowing other companies to manufacture products under their brand or配方.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Gynopolis product offering

Product offering

Core offering

Gynopolis manufactures and distributes a complete range of women's health pharmaceutical formulations spanning fertility care, PCOS management, contraception, menstrual health, lactation support, UTI and vaginal care, and supplementation. The company sells its branded products primarily through a PCD (Propaganda cum Distribution) pharma franchise model, granting franchise holders monopoly distribution rights in designated Indian territories, and additionally offers third-party manufacturing services for gynecological products.

Product overview

Gynopolis is a specialized pharmaceutical company focused exclusively on women's healthcare, operating as a division of Micropolis Lifesciences Private Limited. The company offers a comprehensive portfolio of over 60 gynecological and reproductive health products across 8 major categories including Gynaecology, Lactation Related Products, Menstrual Problem Related Products, Oral Contraceptives, PCOS Management & Female Infertility, Progesterone Range, Supplementation & Nutrition, and UTI & Vaginal Care Products. The product portfolio includes branded formulations such as ALKATWIST, ARGIDAILY, ARGIDAILY PLUS, Carelacto, Clinpolis, CLINPOLIS-TZ, CLOMIPOLIS, Cranpolis, CYSTOKEY, OVAPOLIS, MYDIOL, PREGHOLD series, MENOPOLIS, FOLICOSA, CALDUB, DORNIK-PLUS, GYNOPOLIS-DHA, and contraceptive products like THREEWEEKS and NEXTSTEP-21DAYS. These products address conditions across all stages of a woman's life including early womanhood (menstrual care, UTI treatment), contraception phase, family planning (PCOS, infertility, progesterone-based therapies), and motherhood (lactation support). Gynopolis operates primarily through a PCD (Propaganda cum Distribution) pharma franchise model, providing business opportunities for distributors and entrepreneurs to market these products with monopoly rights in specific territories.

Differentiator

Problem solved

Functional benefit

Brands

  • WinVision: Vision care division mentioned in navigation as part of Micropolis group.
  • Winfertility

Products and services

  • ALKATWIST™ UTI and vaginal care product formulated for treating urinary tract infections in women.
  • ARGIDAILY® L-Arginine 3gm and Proanthocyanidin 75mg granules sachet for PCOS management and female infertility support.
  • ARGIDAILY™ PLUS L-Arginine 3gm with Cyanocobalamine, Vitamin B12, Folic Acid, and DHA granules in orange flavour for female fertility support.
  • Carelacto™ Capsule formulation for lactation support containing Shatavri, Ashwagandha, Yastimadhu, Methi, and Lasuna extracts.
  • Carelacto™ Lactation Powder Powder formulation for supporting healthy lactation and milk supply in nursing mothers.
  • Clinpolis Pharmaceutical product for UTI and vaginal care treatment.
  • CLINPOLIS™ – TZ Combination antibiotic product for treating complex UTI and vaginal infections.
  • CLOMIPOLIS™ M 100 Clomiphene Citrate 100mg with Melatonin 3mg for ovulation induction and PCOS management.
  • Cranpolis® Syrup Cranberry-based suspension for UTI prevention and urinary tract health support.
  • CRANPOLIS™ Cranberry-based formulation for urinary tract infection care and vaginal health.
  • CYSTOKEY™ Myo-Inositol 1000mg with L-Methylfolate and Vitamin D3 tablets for PCOS management and metabolic support.
  • CYSTOKEY™ – MET B/L Myo-Inositol combination with Metformin for enhanced PCOS and metabolic syndrome management.
  • OVAPOLIS-2.5 Letrozole 2.5mg tablet for ovulation induction and fertility treatment.
  • MYDIOL-35 Cyproterone acetate 2mg and Ethinyl estradiol 0.035mg tablet for hormonal balance and acne management in PCOS.
  • PREGHOLD Depot 250 Hydroxyprogesterone Caproate 250mg injection for pregnancy support and prevention of preterm birth.
  • PREGHOLD-MP Medroxyprogesterone Acetate 10mg tablet for hormonal support and menstrual regulation.
  • PREGHOLD 300 SR Micronized Progesterone 300mg sustained release tablet for luteal phase support and fertility treatment.
  • MENOPOLIS Soya Isoflavones, Calcitriol, Calcium, Vitamin K and Magnesium combination for menopause symptom management.
  • ESTRAPOLIS Estradiol Valerate 2mg tablet for hormone replacement therapy.
  • TEXAPOLIS-ET Tranexamic acid 250mg and Etamsylate 250mg combination for menstrual bleeding management.
  • PRIMOTWIST 500 Evening Primrose 500mg supplement for women's health and hormonal balance.
  • TEXAPOLIS-MF Tranexamic acid 500mg and Mefenamic acid 250mg tablet for heavy menstrual bleeding relief.
  • PREGHOLD-200 SR Natural Micronized Progesterone 200mg sustained release tablet for fertility support and hormone balance.
  • FOLICOSA Folic acid 5mg and DHA 200mg supplement for prenatal care and fetal development support.
  • CALDUB Coral Calcium tablet providing Calcium 225mg and Vitamin D3 500IU for bone health support.
  • DORNIK-PLUS Drotaverine 80mg and Mefenamic acid 250mg tablet for menstrual pain and dysmenorrhea relief.
  • PRIMOTWIST 1000 Evening Primrose 1000mg supplement for women's health and hormonal support.
  • GYNOPOLIS-DHA L-methylfolate, Mecobalamine, Pyridoxal 5 phosphate, DHA and Vitamin D3 combination for prenatal nutrition.
  • THREEWEEKS Desogestrel 0.15mg and Ethinyl Estradiol 0.02mg oral contraceptive pill.
  • NEXTSTEP-21DAYS Levonorgestrel 0.15mg and Ethinyl Estradiol 0.03mg oral contraceptive for family planning.
  • DYDROZING™ Dydrogesterone 10mg tablet for progesterone support in fertility treatment and pregnancy maintenance.
  • PCD Pharma Franchise Propaganda cum Distribution franchise opportunity allowing partners to market and distribute Gynopolis gynecological products in designated territories with monopoly rights, with marketing collateral and training support provided.
  • Third-Party Manufacturing Service Contract manufacturing service for gynecological products, allowing other companies to have formulations manufactured under their own brand or composition using Gynopolis's WHO-GMP certified facilities.

Quantifiable outcome

  • 1,75,000+ couples have overcome infertility using Gynopolis fertility formulations
  • +1 more outcomes

Companies that use Gynopolis

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Gynopolis technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Gynopolis partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Micropolis Lifesciences Private LimitedcoreOthersGynopolis is a division of Micropolis Lifesciences Private Limited. As a subsidiary, Gynopolis operates under the parent company's WHO-GMP certifications and infrastructure for manufacturing and distributing gynecological pharmaceutical products.

Scale indicators5 records

Recent moves6 records

Expansion highlights4 records

Gynopolis competitors and assessment

Company assessment

Broad incumbents

  • Mankind Pharma: India's largest PCD-franchise-based pharma company with broad women's health and gynecological offerings. Comparable on the PCD distribution model and women's health category, though it operates across many other therapeutic areas.
  • Sun Pharmaceutical Industries: India's largest pharma company with global scale, broad OB/GYN and hormonal franchises, and deep doctor relationships across India — a dominant incumbent competing for the same prescription volume in gynae.
  • Zydus Cadila: Major Indian pharma with established women's health, hormonal, and supplement brands and a robust India distribution network. A broader incumbent that overlaps with Gynopolis on contraception, hormonal, and supplementation categories.
  • Torrent Pharmaceuticals: Large Indian pharma with dedicated gynecology and women's healthcare marketing divisions. Competes for the same prescriber wallet in gynae therapies but is materially larger and more diversified across geographies.
  • Cipla: India's largest pharma company by certain measures with presence in women's reproductive health, hormonal, and fertility categories. A broad incumbent whose gynae portfolio competes directly with Gynopolis in India's doctor channel.
  • Lupin Limited: One of India's largest pharma companies with a meaningful women's health and hormonal portfolio and pan-India field force. Overlaps with Gynopolis in gynae and fertility but spans far wider therapy areas and global markets.

Direct peers

  • Bharat Serums and Vaccines: India-based specialty pharma with a focused fertility, hormonal, and gynecological portfolio. Its premium niche positioning in reproductive health and its distribution in India overlap closely with Gynopolis's core franchise.
  • Emcure Pharmaceuticals: Indian pharmaceutical company with a strong women's health, fertility, and hormonal therapy portfolio distributed across India via similar field and franchise models, making it a directly comparable gynae specialty peer.

Emerging players

  • Theramex: Global women's health specialty company focused on contraception, fertility, menopause, and osteoporosis — a pure-play peer in women's health, though currently focused on Europe/International rather than India.
  • Organon & Co. Women's health pure-play spun out of Merck with a portfolio in contraception, fertility, and hormone therapy. Closely comparable on therapeutic focus but operates globally rather than via India's PCD franchise model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Gynopolis compliance and trust

Trust signal

Compliance1 record

Gynopolis financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Gynopolis leadership team

Management profile

Number of profiles

Profiles1 record

Gynopolis funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Gynopolis M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gynopolis

What does Gynopolis do?

Gynopolis manufactures and distributes a complete range of women's health pharmaceutical formulations spanning fertility care, PCOS management, contraception, menstrual health, lactation support, UTI and vaginal care, and supplementation. The company sells its branded products primarily through a PCD (Propaganda cum Distribution) pharma franchise model, granting franchise holders monopoly distribution rights in designated Indian territories, and additionally offers third-party manufacturing services for gynecological products.

Is Gynopolis a public or private company?

Gynopolis is a private company. It is classified as corporate owned and is currently operating.

When was Gynopolis founded?

Gynopolis was founded in -1.

Where is Gynopolis based?

Gynopolis is headquartered in Panchkula, India, in the Asia region.

How does Gynopolis make money?

Two revenue lines are on record. PCD Pharma Franchise Product Sales are the primary driver. The others are third Party Manufacturing.

Who are Gynopolis's main competitors?

Broad incumbents on record are Mankind Pharma, Sun Pharmaceutical Industries, Zydus Cadila, Torrent Pharmaceuticals, Cipla and Lupin Limited. Direct peers are Bharat Serums and Vaccines and Emcure Pharmaceuticals. Emerging players are Theramex and Organon & Co..

Does Gynopolis have an API?

No public API is recorded for Gynopolis.

What industry is Gynopolis in?

Gynopolis's product category is Women's Health Pharmaceuticals. Its primary akta.pro industry code is HLAIACAN, Women’s Health & Reproductive Specialty Pharmaceuticals, with a secondary code of HLAIAAAJ, Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health). Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales